1/129
Looks like no tags are added yet.
what are the goals of screening
early detection of disease before clinical manifestation and improve patient quality of life
screening
tests to detect disease before clinical manifestation
diagnostic tests
tests to find the cause of a symptom/clinical manifestation
principles of screening
must be important health problem
natural history should be understood
has a recognizable latent or early symptomatic stage
has a suitable test that is accepted by the population
there must be a policy for who to treat
options must be available for diagnosis and treatment
cost effective and ongoing process
consequences of screening
false positives: false reassurance and delayed treatment
false negative: anxiety and stress
over-diagnosis and over treatment
what is test sensitivity
how well a test can detect a disease
what is test specificity
how well a test identifies patients who DO NOT have disease
a highly sensitive screening test produces:
few false negatives
a highly specific screening test would produce:
very few false positives
what is a false negative
when the test says you don’t have a disease when you do have it
what is a false positive
when the test says you do have a disease but you don’t have it
liver functions
removes toxins
stores vitamins and glucose
makes bile
makes blood clotting regulating factors
metabolic dysfunction associated steatotic liver disease (MASLD)
excessive fat buildup in the liver in the absence of excessive alcohol intake
risk factors for MASLD
type 2 diabetes, obesity, metabolic syndrome
steatosis
abnormal buildup of fat inside an organ
what can MASLD present as
inflammation, steatosis, fibrosis, cirrhosis, cancer
how does MASLD decrease quality of life and increase risk of mortality
buildup of food in the abdomen due to lack of liver enzymes
lack of blood clotting elements
loss of cognitive function
cons of blood tests for MASLD screening
lack sensitivity, 78% of people with MASLD may have normal liver enzymes
MASLD screening
blood tests, ultrasound, liver fat quantification, ultrasound elastrography, CT, MRI, MRI elastrography
pros of ultrasound screening for MASLD
acceptable sensitivity and specificity
non invasive and no radiation
cheap and accessible
cons of ultrasound screening for MASLD
anatomy can affect sensitivity and specificity, operator dependent
what does a hypoechoic liver indicate
high fat in the liver → fatty liver disease
what is liver fat quantification
quantifying the attenuation of a sound beam when it hits the liver
what is ultrasound elastography
using ultrasound to determine liver stiffness
is CT good for MASLD screening
no
why is CT not preferred for MASLD screening
expensive, inaccessible, big radiation
is MRI good for MASLD screening
no
why is MRI not good for MASLD screening
expensive and inaccessible despite being the most accurate
should MASLD be regularly screened in the general population?
no
why not regularly screen for MASLD in the general population
unclear benefit from treatment options, unclear value and cost-effectiveness
EASL 2016 screening guidelines for MASLD
obesity, metabolic syndrome, diabetes, elevated liver enzymes
canadian association for the study of the liver screening guidelines
t2d, obesity, hepatic steatosis, family history
what is hepatocellular carcinoma (HCC)
most common form of liver cancer
risk factors for HCC
cirrhosis, hep B and C, alcohol intake, MASLD
what is the third leading cause of cancer related deaths
HCC
imaging options for HCC
ultrasound, contrast CT, MRI
what is the preferred imaging modality of choice for HCC
ultrasound
what is the preferred imaging modality of choice for MASLD
ultrasound
cons of ultrasound for HCC screening
certain areas of the liver are harder to visualize
lower sensitivity to early stage HCC
affected by body habitus
operator dependent
pros of contrast CT for HCC screening
higher sensitivity and better at detecting early stage HCC
cons of contrast CT for HCC screening
high radiation
expensive
adverse affects of contrast agents
pros of MRI for HCC screening
higher sensitivity and better at detecting early stage HCC
cons of MRI for HCC screening
expensive, time consuming, machine may be incompatible with patient
pros of abbreviated MRI for HCC screening
higher sensitivity, better at detecting early stage HCC, faster, cheaper
cons of abbreviated MRI for HCC screening
low data comparing to ultrasound, may require a recall for a complete exam
which stage of HCC can be cured
early stage
HCC screening guidelines
ultrasound every 6 months for patients with cirrhosis
HCC screening populations for patients w/o cirrhosis
patients with hep c or b, advanced fibrosis, family history of HCC, patients of asian or african descent
primary lung cancer
broad term referring to primary lung malignancies
what is the cause of lung cancer for 90% of cases
smoking tobacco
what is the most commonly diagnosed cancers in BC
lung cancer
how is smoking history measured
pack-years: number of packs smoked daily x number of years smoking
symptoms of lung cancer
asymptomatic for 50% of cases
cough/wheeze/shortness of breath
hemoptysis
pneumonia
pleural effusion
why is lung cancer screening important
can detect the lung cancer before it becomes symptomatic and more serious
when do lung cancer symptoms appear
typically when the disease is at an advanced stage and has spread
who to screen for lung cancer
high risk, asymptomatic populations:
55-74 yrs old
currently smoke or used to smoke <15yrs ago
have a smoking history of >30 pack-years
how to screen for lung cancer
lose dose CT (LDCT) every year for 3 consecutive years
what are you looking for during a lung cancer screening
non-calcified pulmonary nodule
types of lung nodules
solid and subsolid (part-solid, ground glass)
which nodule has the highest probability of malignancy
subsolid nodules
rank the nodules from most to least probability of malignancy
nonsolid> part-solid > solid
growth rate of different lesions
non-solid < solid
is it easier to find peripheral or central nodules
central nodules
what is used for nodule detection
double reader technique using CAD
what do we measure when looking at nodules
size, shape, and growth
how is pulmonary nodule size measured
manual measurement of max diameter, volumetric measurement
when is increased nodule size flagged
increase in mean diameter of 2mm or more for <15mm nodules
15% increase in mean diameter for nodules >15mm
considerations for measuring subsolid nodules
measurement is more complex
if subsolid diameter is stable with solid component increasing → sus asf
main way of obtaining lung lesions
imaging guided biopsy using US, CT, or fluoroscopy
what is planetary health
analyzing and addressing how human disruptions to the earth affects human health
what is the triple planetary crisis
climate change, pollution, and biodiversity loss
changes with the biggest GHG emission impacts
living car free, avoiding a transatlantic flight, plant-based diet, and recycling, divesting from fossil fuels
direct contributors to healthcare GHG emmisions
building heating and anesthetic gases
indirect contributors to healthcare GHG emissions
purchased energy/electricity and supply chain
what is mitigation
reduce emission of GHG into the atmosphere and stabilize GHG levels to give ecosystems time to adapt to climate change impacts
framework for sustainable healthcare in radiology
reduce demand, match supply of health services to demand, reduce emissions from supply of health services
rank the imaging tests use of energy from most to least
interventional > PET > MRI > CT > US
optimizing MRI energy use
power off at night
adjust sequence and protocol length
optimize patient scheduling
optimizing PACS energy use
turning off PACS, laser printers and computers after hours
ways to reduce, reuse/repurpose, and recycle in radiology
reduce IR trays and use of disposable supplies
reuse surgical gowns
repurpose reusable gowns for nonsterile PPE
recycle leftover contrast
secondary prevention
identifying disease early to mitigate complications
tertiary prevention
improving quality of life in those with disease
benefits of early screening
detect disease at early stages for better survival rates
early referral and holistic approach to treatment
support networks, advanced care planning and goals of care
what does high sensitivity and low specificity increase the rate of?
false positive rate = doing unneeded treatment
best screening test
high sensitivity, variable specificity to rule out likelihood of disease
best diagnostic test
high specificity, variable sensitivity to rule in disease
what is the gold standard of brain imaging
contrast MRI
why is contrast MRI the golden standard for brain imaging
good soft tissue contrast and intravenous contrast to highlight blood supply to masses
cons of contrast MRI
long scan time, inaccessible, incompatible with some patients
determinants of brain tumor type
age, genetic conditions, prior radiation exposure
should we screen for asymptomatic brain masses and why
no
no clear benefit to screening + expensive
overdetection bias: discovering benign disease = overtreatment and patient stress
lead time bias: detecting too early creates prolonged survival timeline
length time bias: bias that states that slow growing tumors are more likely to be detected than rapidly growing tumors
population specific screening of intracranial masses
screening for optic gliomas in NF1 patients, patients with genetic conditions, prior cancers, or after head radiation therapy
occurrence of breast cancer in women
85% of breast cancers occur in women w/o family history
risk of breast cancer doubles with first-degree relative with breast cancer
controllable risk factors for breast cancer
combined hormone therapy post menopause
fat and alcohol consumption
lack of exercise
smoking
obesity
uncontrollable risk factors
genetics
chest wall radiation
dense breast tissue
family history
previous atypical cells
early menstruation or late menopause
alcohol guidelines
2 drinks per week. 3-6 drinks per week increases risk of breast cancer, 7+ drinks per week increases risk of CVD
breast cancer screening
self and clinical breast examination
mammography, contrast mammography
US
MRI
molecular breast imaging
why not thermography
can detect superficial cancers but not deeper ones
optimal breast screening protocol
annual mammogram starting at 40 and continuing after menopause
know your breast density
US/MRI/contrast mammography
additional screening guideliners
high risk women
dense breast havers
genetic mutations